Insights for a clearer future

A dynamic platform for global eye health data, trends and insights — informing critical decisions and action.

The Value of Vision: The case for investing in eye health

New research by IAPB, Seva, and The Fred Hollows Foundation confirms that eye health is one of the best buys in global health, with every $1 invested yielding $28 in economic returns.

Age-standardised prevalence of all sight loss, 2020

3-6%

6-9%

9-12%

12-15%

15-18%

18-21%

21-24%

24-27%

27-30%

How to cite: Bourne R, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020. Accessed via the IAPB Vision Atlas.

1.1 billion

people live with sight loss

$411 billion

is lost each year from the global economy due to sight loss

90%

of sight loss is preventable or treatable

The Value of Vision: The case for investing in eye health

Scaling proven solutions to sight loss in low- and middle-income countries will improve eye health, overall health, learning, jobs, and productivity — delivering one of the best returns in global health.

View global summary

A cost-effective digital vision management strategy could reduce childhood myopia in China

A national economic evaluation has demonstrated that a cost-effective AI-empowered digital vision management strategy could significantly reduce childhood myopia, particularly in resource-limited areas.

Written by

Mayinuer Yusufu

China faces escalating childhood myopia crisis with projections reaching 61% by 2050

A comprehensive meta-analysis shows that over one-third of Chinese children have myopia, and if current trends continue, this could rise to 61% by 2050.

Written by

Mayinuer Yusufu

The Value of Vision: The case for investing in eye health

New research by IAPB, Seva, and The Fred Hollows Foundation confirms that eye health is one of the best buys in global health, with every $1 invested yielding $28 in economic returns.